Publications
- Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth. Microbiol Spectr. 2023 Mar 22;11(2):e0433222: Epub ahead of print. PMID: 36946746; PMCID: PMC10100905.
- Potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against SARS-CoV-2 Delta. PLOS Pathogens Apr 28;18(4): e1010465. 2022. (Open access)
- Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative case-control study and a Mechanistic Study of Post-Vaccination Immune Responses. Lancet Infect Dis. (Apr;22(4): 473-482. 2022. (Open access)
- Long-term Durable Humoral Immune Response to Heterologous Antigenic Exposure Post six months by Natural SARS-CoV-2 Infection and Vaccination. medRxiv. doi: https://doi.org/10.1101/2022.02.23.22271381. 2022. (Open access)
- Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities. Retrovirology 18: 12. 2021. (Open access)
- Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity. PLoS ONE. 16(5): e0251969. 2021. (Open access)
- Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer. PLOS Pathogens 17 (4): e1008977. 2021. (Open access)
- Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8. Virus Res. 273: 197763. 2019. (Subscription required)
- The chaperone ERp29 is required for tunneling nanotube formation by stabilizing. MSec. J Biol. Chem. May 3;294(18):7177-7193. 2019. (Subscription required)
- Characterization of the membrane-bound form of the chimeric, B/C recombinant HIV-1 Env, LT5.J4b12C. J Gen. Virol 99 (10): 1438-1443. 2018. (Open access)
- Broad neutralization response in a subset of HIV-1 subtype C-infected viraemic non-progressors from southern India. J Gen Virol. 2018 Mar;99(3):379-392. (Open access)
- Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response. Vaccine. 2018 Mar 14;36(12):1627-1636. 2018. (Subscription required)
- Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail. Retrovirology. 2018 Jul 20;15(1):50. 2018. (Open Access)
- Characterization of a stable HIV-1 B/C recombinant, soluble and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes. Journal of Biological Chemistry. 292 (38): 15849-15858. 2017. (Open Access)
- Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein. J Biol Chem. 292(20):8236-8243. 2017. (Open Access)
- Dual immunity concomitantly suppresses HIV-1 progression. Trends in Microbiol. 25 (5): 334-335. 2017. (Subscription required)
- Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies. Retrovirology 13: 41. 2016. (Open Access)
- HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms. Retrovirology 30;13(1):60. 2016. (Open Access)
- Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C Infected Elite Neutralizer Mediate Autologous Virus Escape through Novel Mutations in V1 Loop. Journal of Virology 90 (7): 3446-3457. 2016. (Open Access)
- Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual. PLOS One; 2015 May 11;10(5): e0125575. 2015. (Open Access)
- An efficiently cleaved HIV-1 clade C Env selectively binds to neutralizing antibodies. PLOS One; 2015 Mar 30;10(3): e0122443. 2015. (Open Access)
- Determinants in V2C2 region of HIV-1 clade C primary envelopes conferred altered neutralization susceptibilities to IgG1b12 and PG9 monoclonal antibodies in context dependent manner. Virology 462-463: 266–272. 2014.